Cargando…
Concomitant medications, functional foods, and supplements: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022
BACKGROUND: This Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) is intended to provide clinicians an overview of the body weight effects of concomitant medications (i.e., pharmacotherapies not specifically for the treatment of obesity) and functional foods, as well as adverse s...
Autores principales: | Tondt, Justin, Bays, Harold Edward |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661915/ https://www.ncbi.nlm.nih.gov/pubmed/37990714 http://dx.doi.org/10.1016/j.obpill.2022.100017 |
Ejemplares similares
-
Thirty Obesity Myths, Misunderstandings, and/or Oversimplifications: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022
por: Bays, Harold Edward, et al.
Publicado: (2022) -
Anti-Obesity Medications and Investigational Agents: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022
por: Bays, Harold E., et al.
Publicado: (2022) -
Cancer and Obesity: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022
por: Lazarus, Ethan, et al.
Publicado: (2022) -
Sleep-disordered breathing, sleep apnea, and other obesity-related sleep disorders: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022
por: Pennings, Nicholas, et al.
Publicado: (2022) -
Obesity history, physical exam, laboratory, body composition, and energy expenditure: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022
por: Burridge, Karlijn, et al.
Publicado: (2022)